5.0 based on 4 reviewsView this provider's reviews
Patient satisfaction ratings and reviews are based on personal opinions. Before you choose any doctor you should take into account their background, training, specialized experience AND their patient satisfaction to ensure they are the right fit for you.
Accepting new patients
Dr. Stanley Fahn, MD is a neurology specialist in New York, NY and has been practicing for 50 years. He specializes in neurology.Read his story
This content was provided by Dr. Fahn "Stanley Fahn, MD is the H. Houston Merritt Professor of Neurology and Director of the Center for Parkinson's Disease and Other Movement Disorders at Columbia University. He is the Scientific Director of the Parkinson's Disease Foundation. He has served as a member of the Scientific Advisory Board of the Dystonia Clinical Medical Research Foundation and is currently a lifetime honorary member of its Board of Directors. Dr. Fahn had served as the founding director of the Dystonia Clinical Research Center at Columbia University, funded by this foundation. He previously served on the Medical Advisory Board of the Myoclonus Research Foundation, the Scientific Advisory Board of American Parkinson's Disease Association, and chaired the Medical Advisory Board of the Committee to Combat Huntington Disease. He currently chairs the Parkinson's Community Research Advisory Council of the Michael J. Fox Foundation for Parkinson Research. He was Vice President, subsequently President Elect, and was then President of the American Academy of Neurology (AAN) from 2001-2003. He has served as Second Vice President of the American Neurological Association. He served on several committees, including chairman of some, for both these professional organizations. He founded and served as the Chairman of the Steering Committee of the Movement Disorder Society, an international organization of professionals active in this subspecialty. After its constitution was approved, he was elected its first president. He was the founding co editor of the journal Movement Disorders, and served in this capacity for the first 10 years of the journal's existence, until 1996. He has also served as Associate Editor of Neurology for 10 years. He is a member of the World Federation of Neurology Working Group on Extrapyramidal Diseases. Dr. Fahn has twice served as Chairman of the Advisory Committee on Peripheral and Central Nervous System Drugs for the Food and Drug Administration. Dr. Fahn organizes and lectures in the annual course on Movement Disorders held in Aspen, Colorado, each summer. He organized the course on Movement Disorders for the AAN's self improvement program, Continuum. He also organized and chaired the first series of Movement Disorder courses at the AAN's annual meeting beginning in 1986 and has lectured in this course every year for more than 10 years, as well as a number of other courses at the AAN. He also founded the Unusual Movement Disorders Seminar at the AAN in 1981 and organized this seminar annually until he stepped aside after the 2001 seminar. Dr. Fahn has published many scientific papers on Parkinson disease and other movement disorders. In December 2002, he was listed as one of the most highly cited authors by the Institute of Scientific Information. He has been invited to write reviews and chapters and to lecture nationally and internationally on the diagnosis, classification and treatment of a variety of movement disorders. He participated in the development of rating scales for Parkinson's disease, dystonia, tremor and Huntington disease. He organized and executed the development of the Unified Parkinson's Disease Rating Scale (UPDRS) and modified and popularized the use of the Schwab England ADL score for global severity of this disease. Both of these rating scores are used world wide, the former to determine the severity of Parkinson disease (PD), and the latter as a measure of quality of life. For dystonia, he co developed with David Marsden the Fahn Marsden rating scale; for Huntington disease he co developed the Shoulson Fahn rating scale, and for levodopa-induced dyskinesias, the Lang-Fahn Dyskinesia ADL scale."
This content was provided by Dr. Fahn "We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person. "
1 Board Certifications
Accredited by: American Board of Psychiatry & Neurology*